BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

61 related articles for article (PubMed ID: 10635772)

  • 21. Human liver Kupffer cells express CR1, CR3, and CR4 complement receptor antigens. An immunohistochemical study.
    Hinglais N; Kazatchkine MD; Mandet C; Appay MD; Bariety J
    Lab Invest; 1989 Nov; 61(5):509-14. PubMed ID: 2478758
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Chemotactic factor-induced low density neutrophils express enhanced complement (CR1 and CR3) receptors and increased complement-dependent cytotoxicity.
    Moqbel R; Richerson HB; MacDonald AJ; Walsh GM; Hartnell A; Walport MJ; Kay AB
    Clin Exp Immunol; 1987 Sep; 69(3):676-86. PubMed ID: 2959415
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The human C3b receptor (CR1).
    Weiss L; Fischer E; Haeffner-Cavaillon N; Jouvin MH; Appay MD; Bariety J; Kazatchkine M
    Adv Nephrol Necker Hosp; 1989; 18():249-69. PubMed ID: 2522267
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Distribution in clusters of complement receptor type one (CR1) on human erythrocytes.
    Chevalier J; Kazatchkine MD
    J Immunol; 1989 Mar; 142(6):2031-6. PubMed ID: 2522131
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Low number of complement C3b/C4b receptors (CR1) on erythrocytes from patients with essential mixed cryoglobulinemia, systemic lupus erythematosus and rheumatoid arthritis: relationship with disease activity, anticardiolipin antibodies, complement activation and therapy.
    Corvetta A; Pomponio G; Bencivenga R; Luchetti MM; Spycher M; Spaeth PJ; Danieli G
    J Rheumatol; 1991 Jul; 18(7):1021-5. PubMed ID: 1833542
    [TBL] [Abstract][Full Text] [Related]  

  • 26. CR1 deficiency in patients with Hansen's disease.
    Tausk FA; Schreiber RD; Gigli I
    Trans Assoc Am Physicians; 1984; 97():346-52. PubMed ID: 6242085
    [No Abstract]   [Full Text] [Related]  

  • 27. [Flow cytometric measurement of C3b receptors (CR1) on human erythrocytes].
    Itoh Y; Fukunaga Y; Yamamoto M; Ueda Y
    Arerugi; 1987 May; 36(5):277-87. PubMed ID: 2959242
    [No Abstract]   [Full Text] [Related]  

  • 28. Differential effects of the stimulation of complement receptors CR1 (CD35) and CR2 (CD21) on cell proliferation and intracellular Ca2+ mobilization of chronic lymphocytic leukemia B cells.
    Hivroz C; Fischer E; Kazatchkine MD; Grillot-Courvalin C
    J Immunol; 1991 Mar; 146(6):1766-72. PubMed ID: 1826011
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Complement receptors.
    Holers VM
    Year Immunol; 1989; 4():231-40. PubMed ID: 2538973
    [No Abstract]   [Full Text] [Related]  

  • 30. [Immunologic tests: C3 receptor (CR1, 2)].
    Okuda N; Seya T
    Nihon Rinsho; 2005 Jul; 63 Suppl 7():67-70. PubMed ID: 16111190
    [No Abstract]   [Full Text] [Related]  

  • 31. Flow cytometric assay for phagocytosis of human monocytes mediated via Fc gamma-receptors and complement receptor CR1 (CD35).
    Andoh A; Fujiyama Y; Kitoh K; Hodohara K; Bamba T; Hosoda S
    Cytometry; 1991; 12(7):677-86. PubMed ID: 1838328
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Expansion of the complement receptor gene family. Identification in the mouse of two new genes related to the CR1 and CR2 gene family.
    Aegerter-Shaw M; Cole JL; Klickstein LB; Wong WW; Fearon DT; Lalley PA; Weis JH
    J Immunol; 1987 May; 138(10):3488-94. PubMed ID: 2952719
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Erythrocyte CR1 receptor reactivity in patients with systemic lupus erythematosus].
    Said PB; Sarano J; Manni JA; Casellas AM
    Medicina (B Aires); 1990; 50(1):21-4. PubMed ID: 2149869
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Novel roles for murine complement receptors type 1 and 2 I. Regulation of B cell survival and proliferation by CR1/2.
    Molnár E; Erdei A; Prechl J
    Immunol Lett; 2008 Mar; 116(2):156-62. PubMed ID: 18243341
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Erythrocyte CR1 receptors in patients with hypogammaglobulinaemia.
    Lever AM; Webster AD
    Int Arch Allergy Appl Immunol; 1988; 85(3):329-31. PubMed ID: 2965110
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Epstein-Barr virus/complement receptor and epithelial cells.
    Lancet; 1989 Aug; 2(8660):448-50. PubMed ID: 2569630
    [No Abstract]   [Full Text] [Related]  

  • 37. Pitfalls in the measurement of soluble forms of cell surface receptors.
    Ling NR
    Clin Exp Immunol; 1993 Aug; 93(2):139-41. PubMed ID: 8348738
    [No Abstract]   [Full Text] [Related]  

  • 38. [C3 receptor (CR1, 2, 3, 4)].
    Seya T
    Nihon Rinsho; 1999 Nov; 57 Suppl():50-4. PubMed ID: 10635772
    [No Abstract]   [Full Text] [Related]  

  • 39. Deficiencies of human C3 complement receptors type 1 (CR1, CD35) and type 2 (CR2, CD21).
    Kazatchkine MD; Fearon DT
    Immunodefic Rev; 1990; 2(1):17-41. PubMed ID: 2164822
    [TBL] [Abstract][Full Text] [Related]  

  • 40. CR1(CD35) and CR2(CD21) complement C3 receptors are expressed on normal human thymocytes and mediate infection of thymocytes with opsonized human immunodeficiency virus.
    Delibrias CC; Mouhoub A; Fischer E; Kazatchkine MD
    Eur J Immunol; 1994 Nov; 24(11):2784-8. PubMed ID: 7957570
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.